-
Subject Areas on Research
-
A comparison of adverse reaction rates for PAS C versus plasma platelet units.
-
Acute profound thrombocytopenia after C7E3 Fab (abciximab) therapy.
-
Bacterial contamination of platelets for transfusion: strategies for prevention.
-
Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components.
-
Critical developments of 2018: A review of the literature from selected topics in transfusion. A committee report from the AABB's Clinical Transfusion Medicine Committee.
-
Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: changing impact of risk factors.
-
Defining Usage and Clinical Outcomes Following Perioperative Fresh Frozen Plasma and Platelet Administration in Spine Surgery Patients.
-
Does a febrile reaction to platelets predispose recipients to red blood cell alloimmunization?
-
Dose of prophylactic platelet transfusions and prevention of hemorrhage.
-
Editorial: platelet transfusions in cirrhosis-do the risks outweigh the unclear benefits?
-
Effect of Antifibrinolytic Therapy on Complications, Thromboembolic Events, Blood Product Utilization, and Fusion in Adult Spinal Deformity Surgery.
-
Effects of ABO Matching of Platelet Transfusions in Critically Ill Children.
-
Encouraging single-unit transfusions: a superior patient blood management strategy?
-
Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases.
-
Evaluation of amotosalen and UVA pathogen-reduced apheresis platelets after 7-day storage.
-
Factors associated with red blood cell, platelet, and plasma transfusions among inpatient hospitalizations: a nationally representative study in the United States.
-
Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment.
-
High-dose intravenous immunoglobulin for severe platelet alloimmunization.
-
Human platelets activate porcine endothelial cells through a CD154-dependent pathway.
-
Implementation of a pediatric trauma massive transfusion protocol: one institution's experience.
-
Infectious complications after cardiac surgery: lack of association with fresh frozen plasma or platelet transfusions.
-
International Study of the Epidemiology of Platelet Transfusions in Critically Ill Children With an Underlying Oncologic Diagnosis.
-
Lack of efficacy for conventional gamma irradiation of platelet concentrates to abrogate bacterial growth.
-
Manufacture of Autologous CD34+ Selected Grafts in the NIAID-Sponsored HALT-MS and SCOT Multicenter Clinical Trials for Autoimmune Diseases.
-
Marrow transplantation for thalassaemia.
-
Murine monoclonal anti-T cell antibodies for treatment of steroid-resistant acute graft-versus-host disease.
-
Neonatal alloimmune thrombocytopenic purpura.
-
Perioperative Management of the Gynecologic Patient on Long-term Anticoagulation.
-
Perioperative Removal of Autologous Platelets.
-
Platelet Transfusion Practice and Related Outcomes in Pediatric Extracorporeal Membrane Oxygenation.
-
Platelet Transfusion Practices in Critically Ill Children.
-
Platelet transfusion increases risk for acute respiratory distress syndrome in non-massively transfused blunt trauma patients.
-
Platelet transfusion reactions: febrile nonhemolytic reaction or bacterial contamination? Diagnosis, detection, and current preventive modalities.
-
Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes.
-
Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154.
-
Pregnancy in patients with thrombocytopenia and absent radii (TAR) syndrome.
-
Reduced use of allogeneic platelets through high-yield perioperative autologous plateletpheresis and reinfusion.
-
Reduction in blood transfusion in a cohort of infants having cardiac surgery with cardiopulmonary bypass after instituting a goal-directed transfusion policy.
-
Residual risk of D alloimmunization: is it time to feel safe about platelets from D+ donors?
-
Results of lookback for Chagas disease since the inception of donor screening at New York Blood Center.
-
Reticulated platelet counts in patients undergoing autologous bone marrow transplantation: an aid in assessing marrow recovery.
-
Seasonal variability is not observed in the rates of high anti-A and anti-B titers in plasma, apheresis platelet, and whole blood units tested by different methods.
-
Secondary failure of platelet recovery after hematopoietic stem cell transplantation.
-
Septic risk increases with apheresis platelet storage time.
-
Storage age of transfused platelets and outcomes after cardiac surgery.
-
Therapeutic Plasma Transfusion in Bleeding Patients: A Systematic Review.
-
Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research.
-
Transfusion outcomes in patients undergoing coronary artery bypass grafting treated with prasugrel or clopidogrel: TRITON-TIMI 38 retrospective data analysis.
-
Treatment of platelet alloimmunization with intravenous immunoglobulin. Two case reports and review of the literature.
-
Understanding thrombocytopenia and antigenicity with glycoprotein IIb-IIIa inhibitors.
-
Update on multi-center clinical trials in the United States.
-
Variation in use of blood transfusion in coronary artery bypass graft surgery.
-
Vincristine therapy for severe platelet alloimmunization.
-
Warming Up to Cold-stored Platelets.
-
What Is the PROPPR Transfusion Strategy in Trauma Resuscitation?
-
What is the evidence for platelet transfusion in perioperative settings?
-
Keywords of People